News Headlines Article

Drug industry on edge for Obama action on prices
The Hill

The pharmaceutical industry is anxiously awaiting a series of regulatory actions from the Obama administration aimed at combating high drug prices.

Drug prices have been a major issue on the campaign trail, with Hillary Clinton and Bernie Sanders pounding pharmaceutical companies. Martin Shkreli, the ex-pharmaceutical company CEO who made headlines for hiking the price of a life-saving drug by 5,000 percent, also has put the issue of drug prices in the spotlight.